FDA approves Syndax blood cancer drug
![](https://4gi.tv/wp-content/uploads/2024/11/1811-ws-he2-1024x576.jpg)
The US Food and Drug Administration has approved Syndax Pharmaceuticals’ drug for the treatment of adult and paediatric patients with a type of blood cancer. The drug revumenib is used to treat acute leukaemia with a KMT2A translocation.
BELIEBTE BEITRÄGE
![](https://4gi.tv/wp-content/uploads/2024/12/1712-ws-env2.jpg)
Earthquakes and emissions undermine the idea of carbon storage in Texas
Dezember 17, 2024
![](https://4gi.tv/wp-content/uploads/2024/12/1712-ws-env1.jpg)
![](https://4gi.tv/wp-content/uploads/2024/12/1712-ws-env.jpg)
Rescuers search for cyclone survivors in devastated Mayotte
Dezember 17, 2024
![](https://4gi.tv/wp-content/uploads/2024/12/1712-ws-cul2.jpg)
“Gilmore Girls” airs for a second season on Hulu
Dezember 17, 2024
LIVEÜBERTRAGUNG